18 January 2012

BSE, Bulk deals, 18/1/2012

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Deal DateScrip CodeCompanyClient NameDeal Type *QuantityPrice **
18/1/2012526707AlchemistBP FINTRADE PRIVATE LIMITEDB6163259.65
18/1/2012526707AlchemistBP FINTRADE PRIVATE LIMITEDS6750059.80
18/1/2012590006Amrutanjan Health-$Quadeye Securities Pvt LtdB16376835.95
18/1/2012590006Amrutanjan Health-$CROSSEAS CAPITAL SERVICES PRIVATE LIMITEDB20938834.12
18/1/2012590006Amrutanjan Health-$A K G STOCK BROKERS PRIVATE LIMITEDB16061834.64
18/1/2012590006Amrutanjan Health-$A K G SECURITIES AND CONSULTANCY LTDB37592840.14
18/1/2012590006Amrutanjan Health-$CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITEDB52263837.30
18/1/2012590006Amrutanjan Health-$A K G STOCK BROKERS PRIVATE LIMITEDS16061834.44
18/1/2012590006Amrutanjan Health-$A K G SECURITIES AND CONSULTANCY LTDS37592840.66
18/1/2012590006Amrutanjan Health-$Quadeye Securities Pvt LtdS16376836.42

18/1/12: Categories Turnover (BSE) (Rs. crore)

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��



Categories Turnover (BSE)
(Rs. crore)
ClientsNRIProprietary
Trade DateBuySalesNetBuySalesNetBuySalesNet
18/1/121,709.601,681.5128.092.160.301.86586.40589.19-2.80
17/1/121,716.101,781.39-65.292.320.651.67607.83594.8412.99
16/1/121,439.151,432.616.540.621.22-0.59508.41500.807.62
Jan , 1219,576.0219,695.92-119.9110.226.903.326,867.236,698.33168.90
Since 1/1/1219,576.0219,695.92-119.9110.226.903.326,867.236,698.33168.90

18/1/12: FII & DII Turnover (BSE + NSE) (Rs. crore)

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� �




FII & DII Turnover (BSE + NSE)
(Rs. crore)
FIIDII
Trade DateBuySalesNetBuySalesNet
18/1/123,008.082,132.23875.85884.511,474.78-590.27

NSE, Bulk deals, 18-Jan-2012

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


DateSymbolSecurity NameClient NameBuy / SellQuantity TradedTrade Price /
Wght. Avg.
Price
Remarks
18-Jan-2012AMRUTANJANAmrutajan Health LtdCHANDARANA INTERMEDIARIES BROKERS P. LTDBUY52,504838.97-
18-Jan-2012AMRUTANJANAmrutajan Health LtdCHANDARANA INTERMEDIARIES BROKERS P. LTDSELL52,504837.97-
18-Jan-2012AMRUTANJANAmrutajan Health LtdCROSSEAS CAPITAL SERVICES PVT. LTD.BUY21,288831.60-
18-Jan-2012AMRUTANJANAmrutajan Health LtdCROSSEAS CAPITAL SERVICES PVT. LTD.SELL21,288835.36-
18-Jan-2012AMRUTANJANAmrutajan Health LtdDINESH MUNJALBUY20,419837.44-
18-Jan-2012AMRUTANJANAmrutajan Health LtdDINESH MUNJALSELL20,419838.85-
18-Jan-2012AMRUTANJANAmrutajan Health LtdEXCEL MERCANTILE PRIVATE LIMITEDBUY20,411839.24-
18-Jan-2012AMRUTANJANAmrutajan Health LtdEXCEL MERCANTILE PRIVATE LIMITEDSELL20,411839.41-
18-Jan-2012AMRUTANJANAmrutajan Health LtdMOHIT GUJRALBUY16,455842.71-
18-Jan-2012AMRUTANJANAmrutajan Health LtdMOHIT GUJRALSELL16,455841.52-
18-Jan-2012AMRUTANJANAmrutajan Health LtdNIKON FINLEASE PVT. LTDBUY34,257840.84-
18-Jan-2012AMRUTANJANAmrutajan Health LtdNIKON FINLEASE PVT. LTDSELL34,257840.53-
18-Jan-2012BEDMUTHABedmutha Indust LtdNITIN BABAJI PALANDEBUY1,16,66833.69-
18-Jan-2012BEDMUTHABedmutha Indust LtdNITIN BABAJI PALANDESELL1,09,96832.97-
18-Jan-2012ELFORGEEL Forge LimitedKANNAN VISHWANATHBUY3,01,0009.00-
18-Jan-2012ELFORGEEL Forge LimitedTEAM INDIA MANAGERS LIMITEDSELL3,00,0009.00-

Fortnightly round up of key banking and economic indicators · :Emkay

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Fortnightly round up of key banking and economic indicators
·      Non-food credit growth at 15.7% yoy is on a decline and appears lower primarily due to higher base of the previous year (24.2% yoy). On qoq basis, the growth came in at 6.4%. On YTD basis, growth is up 11%
·      …resultant, RBI target of 18% yoy for FY12 appears on higher end. On other hand, growth in total deposits at 17% yoy is well within RBI target zone. Demand deposits were up 14% over previous fortnight and flat YTD
·      CD ratio has remained steady at 75% levels for past several fortnights. Inc. CDR came in at 70% levels. Money supply growth improved to 16% yoy. With M1 growth at 7% yoy, the ratio of M3/M1 has eased to 4.26x levels
·      Liquidity remained tight with net outflow at ~Rs1.5tn (2.6% of NDTL) as on Jan-16. The additional borrowing programme with expectation of credit growth up-tick is likely to keep LAF in deficit mode in H2FY12
·      Rs560bnof OMO operations have enabled 10-yr/1-yr G-sec to ease by ~60bps+ from their recent highs. However, tight liquidity with higher borrowing programme will hold the yield curve at current levels
·      Call money rates have eased to 8.6% levels. The spread of 10-yr Gsec over AAA corporate bond has remained at ~100bps.
·      WPI Inflation for Dec’11 came in at 7.5% levels. Given the backdrop of sharp decline in inflation and the slow down in the IIP growth (3.8% YTD), we believe that there is a strong case for the RBI to initiate a CRR cut

FII DERIVATIVES STATISTICS FOR 18-Jan-2012

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


FII DERIVATIVES STATISTICS FOR 18-Jan-2012 
 BUYSELLOPEN INTEREST AT THE END OF THE DAY 
 No. of contractsAmt in CroresNo. of contractsAmt in CroresNo. of contractsAmt in Crores 
INDEX FUTURES657161622.00808451992.3455229613565.16-370.34
INDEX OPTIONS54736513352.6651832112674.95152191737674.84677.70
STOCK FUTURES1116582873.871113472880.34108895027852.81-6.46
STOCK OPTIONS409361051.4537351951.00605731607.56100.46
      Total401.36


-- 

5 financial blunders to avoid and become richer in 2012 (Rediff)

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Most investors sell in panic, act like traders, don't understand the difference between price of a stock and its value, are not consistent in their investment strategy and deviate from their asset allocations that leads to wealth destruction, writes Ramalingam K.
John Bogle, Vanguard founder and inventor of index funds: Your success in investing will depend in part on your character and guts, and in part on your ability to realise at the height of the ebullience and the depth of despair alike that this too shall pass.
The Indian stock market's bellwether Sensex fell more than 20 per cent in 2011. And the so-called experts have predicted that 2012 will not be a great year for stock market investors either. But it doesn't mean that you should stay away from investing in stocks in 2012. Because many of these so-called experts were not very bullish about the market in 2009 when the Sensex skyrocketed 80 per cent after a steep fall to 8,500.
So instead of predicting the market you should understand the blunders you need to avoid in 2012 as an investor. That will help you make more money.
The author, an MBA (Finance) and certified financial planner, is the director of Holistic Investment Planners


1. Don't sell in panic
John Bogle: If you have trouble imagining a 20 per cent loss in the stock market, you shouldn't be in stocks.
Warren Buffett: If a business does well, the stock eventually follows. 
This wisdom from the two legendary investors rightly applies to reacting in falls in the stocks with special reference to the recent fall of blue chip stocks like Reliance Industries, State Bank of India and L&T.
The nervousness and panic selling is absolutely uncalled for as these stocks would soon bounce back. We have seen it also as the Sensex shot up from 8,500 in March 2009 to 16,000 at the end of 2009 under the shadow of the global economic meltdown.
In most cases such tendencies are temporary even in the global market. Smart investors should best buy and not sell blue chip stocks during a market fall, once they are convinced about the fundamentals of the blue chip companies.

Escorts - Value Pick:: Anand Rathi

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��



Closing 76                              BUY                      Target 140

 Investment Rationale 

~ Business performance – agri mechanization -pioneer

~ Reversal in product-mix towards high-HP tractors

~ Looking ahead with new strategies

~ Technical collaboration to expand business focus

~ Capex plans

~ Industry demand

Outlook & Valuations

Looking at the company and the industry, there are clear concerns. Being an agri-mechanism pioneer and with its efforts to expand would work in its favour. Also, Escorts is low on debt, and has ~Rs.3,191 million in cash on hand. With capacity utilization at lower levels (~62% FY1009) there is huge scope for improved utilization levels and cope up with the increasing demand going forward. Also Escorts is regaining its markets share from its new strategies, also the construction equipment business and the railway equipment business will register good growth after improved economic outlook and huge spending by the government as well.

At the CMP, the stock trades at 5.7x FY12 and 4.3x FY13 estimated earnings (The company has a September year-end). We see a price of Rs.140 within two years . 

Quarterly Results Preview METALS OCTOBER-DECEMBER’11 Stress continues:: ICICI Sec

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Indian metal stocks have sharply underperformed their regional and global peers with India
losing its inherent profitability on account of iron ore issues, increasing power / employee
costs and steep interest cost cycle. The extent of underperformance is relatively lower in
the non-ferrous segment in spite of our assessment that loss in relative profitability is much
steeper in the non-ferrous space (aluminium) vis-à-vis steel. The quarter reiterates our
assessment with Aluminum EBITDA and adjusted PAT going down 23% and 17% YoY visà-
vis 14% and 7% for the ferrous space (excluding Tata Steel Europe [TSE]). The only
commodity where India has retained its profitability is zinc where Hindustan Zinc (HZL)
outperformed its global and regional peers across the value chain. Sterlite (SIL) continues
to reel under investor concern of possible equity reinfusion in Sterlite Energy (SEL) and
Vedanta Aluminium (VAL). Margin pressures will define Q4FY12 earnings as well with
partial relief flowing in not before Q1FY13, and that too for ferrous players.
• Steel – Domestic demand uncertainty, increasing cost base, lower profitability
drive incremental underperformance: Higher raw material costs and stickiness in
pricing will lead to ~400bps YoY margin drop for Tata Steel India, SAIL and JSW Steel
(JSWS). We expect TSE to post an EBITDA loss of US$30/te in the quarter. A
possible increase in pension liabilities post the triennial valuations and asset
impairment with potential increase in goodwill has opened the scope of further
reduction in adjusted book value of the company, leading to further investor concerns.
• Sesa Goa – Goa poses additional risk; NMDC offers balanced risk-reward:
Q3FY12 will reflect the full impact of the Karnataka mining ban. Increase in export duty
to 30%, possible impact of M.B. Shah Commission’s report in Goa and impasse in
Karnataka leave out any meaningful growth opportunities in FY13. Sesa has higher
investment value than core operational value. With meaningful volume accretion
possibilities, scope of consensus upgrades and beaten down valuation, NMDC offers a
much better risk reward. We expect NMDC’s top line and EBITDA to increase 16%
and 21% YoY respectively in Q3FY12.
• Non-ferrous – Aluminium the weak link: Irreversible cost pressures in Aluminium
are leading to underperformance of the domestic players against the regional and the
global peers, and this is set to continue. Further, slip-ups in project implementation will
act as a long-term headwind for the space. SIL continues to fight profit erosion in SEL,
where incremental equity contribution from SIL will be soon required. Investor
concerns exist on further equity contribution from SIL to VAL as well (a risk that might
be temporarily avoided due to benevolent lending by SBI). Lead volumes can again
play a spoilsport for HZL, and chances of negative surprise in Q3FY12 are high.